55 Whitney Avenue, New Haven, CT
Our proprietary single-cell multiplexing micro-immunoassay and software enable new therapeutic and diagnostic discovery opportunities
Protein antibody-based multiplexing provides
characterization of the most influential cell subsets based on their functional phenotype.
Single cell analysis facilitates determination of cellular subsets among heterogeneous cancer and immune cell populations